BCL2L12 and acute myeloid leukemia: Comparison revealed no statistical significant relation between high and low BCL2L12 gene expression in AML patients regarding demographic and clinical data: age (P value:0.45), hepatomegaly (P value: 0.66) and splenomegaly (P value: 0.73) and lymphadenopathy (P value: 0.65).